Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma
鉴定并验证 ERK5 作为胶质母细胞瘤中调节 DNA 损伤的药物靶点
期刊:Cancers
影响因子:
doi:10.3390/cancers13050944
Natasha Carmell, Ola Rominiyi, Katie N Myers, Connor McGarrity-Cottrell, Aurelie Vanderlinden, Nikita Lad, Eva Perroux-David, Sherif F El-Khamisy, Malee Fernando, Katherine G Finegan, Stephen Brown, Spencer J Collis
信号转导
其它细胞
FCM
IF
IHC-P
WB
MAPK/ERK
